Clarius Group LLC’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,000
Closed -$7K 519
2022
Q3
$7K Hold
10,000
﹤0.01% 494
2022
Q2
$19K Hold
10,000
﹤0.01% 469
2022
Q1
$43K Hold
10,000
﹤0.01% 493
2021
Q4
$43K Hold
10,000
﹤0.01% 493
2021
Q3
$60K Hold
10,000
0.01% 429
2021
Q2
$83K Hold
10,000
0.01% 419
2021
Q1
$86K Hold
10,000
0.01% 381
2020
Q4
$121K Hold
10,000
0.01% 343
2020
Q3
$163K Hold
10,000
0.02% 284
2020
Q2
$150K Hold
10,000
0.02% 275
2020
Q1
$73K Hold
10,000
0.01% 252
2019
Q4
$58K Hold
10,000
0.01% 295
2019
Q3
$42K Hold
10,000
0.01% 278
2019
Q2
$38K Buy
+10,000
New +$35.4K 0.01% 263
2018
Q4
Sell
-10,000
Closed -$39K 125
2018
Q3
$39K Hold
10,000
0.01% 123
2018
Q2
$33K Hold
10,000
0.01% 90
2018
Q1
$45K Hold
10,000
0.02% 65
2017
Q4
$25K Hold
10,000
0.01% 67
2017
Q3
$38K Hold
10,000
0.02% 69
2017
Q2
$38K Buy
+10,000
New +$41.6K 0.02% 95
2016
Q3
Sell
-10,000
Closed -$65K 95
2016
Q2
$65K Hold
10,000
0.03% 85
2016
Q1
$55K Hold
10,000
0.03% 84
2015
Q4
$63K Buy
+10,000
New +$65.6K 0.04% 77

Other funds holding CGEN

Clarius Group LLC's CGEN Position: Q4 2022 in Review

Clarius Group LLC sold out of Compugen (CGEN) in Q4 2022, closing a stake of 10,000 shares — an estimated $7K sold.

Clarius Group LLC first reported a position in CGEN in Q4 2015 and held it in 23 quarters. The position peaked at $163K in Q3 2020. 74 funds tracked by Wall St. Rank hold CGEN as of Q4 2022.

  • Clarius Group LLC reported no remaining Compugen position as of Q4 2022 after selling out during the quarter.
  • Clarius Group LLC sold 10,000 Compugen shares in Q4 2022, an estimated $7K.
  • Clarius Group LLC first reported a position in Compugen in Q4 2015 and held it in 23 quarters.
  • Clarius Group LLC's Compugen position peaked at $163K in Q3 2020.
  • 74 funds tracked by Wall St. Rank held Compugen as of Q4 2022.

Based on Clarius Group LLC's 13F filing for Q4 2022, filed 25 Jan 2023.